Valeant Pharmaceuticals said it would hike its cash-and-stock offer to buy Botox-maker Allergan -- a move that's backed by Pershing Square's Bill Ackman.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
